IL2 and myeloid sarcoma: Among those, we found a statistically significant increase in the levels of GM-CSF, IL-2, IL-12, and IL-1β in MS patients when compared to HCs (Mann–Whitney, no correction for multiple measurements as nonindependent, HC n = 10; MS n = 14: GM-CSF p = 0.026; IL-2 p = 0.041; IL-12 p = 0.028; and IL-1β p = 0.041; Figure 6).